A Study of Tor Kinase Inhibitor in Advanced Tumors
The purpose of the study is to assess the safety, tolerability and pharmacokinetics of AZD8055 and determine the maximum tolerated dose to take into phase II trials.
Solid Tumors
DRUG: AZD8055
Safety and tolerability of AZD8055, Assessed at all visits
To identify early signals of anti-tumour activity, Visits 1, 5, and 9 and 11|To identify early signals of anti-tumor activity, Visits 1, 5, 9 and 13
The purpose of the study is to assess the safety, tolerability and pharmacokinetics of AZD8055 and determine the maximum tolerated dose to take into phase II trials.